These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 9893101

  • 21. CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study.
    Kaufmann GR, Perrin L, Pantaleo G, Opravil M, Furrer H, Telenti A, Hirschel B, Ledergerber B, Vernazza P, Bernasconi E, Rickenbach M, Egger M, Battegay M, Swiss HIV Cohort Study Group.
    Arch Intern Med; 2003 Oct 13; 163(18):2187-95. PubMed ID: 14557216
    [Abstract] [Full Text] [Related]

  • 22. Secular trends in the survival of HIV-infected homosexual men in Amsterdam and Vancouver estimated from a death-included CD4-staged Markov model.
    Hendriks JC, Craib KJ, Veugelers PJ, van Druten HA, Coutinho RA, Schechter MT, van Griensven GJ.
    Int J Epidemiol; 2000 Jun 13; 29(3):565-72. PubMed ID: 10869332
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Clinical experience of the 23-valent capsular polysaccharide pneumococcal vaccination in HIV-1-infected patients receiving highly active antiretroviral therapy: a prospective observational study.
    Hung CC, Chen MY, Hsieh SM, Hsiao CF, Sheng WH, Chang SC.
    Vaccine; 2004 May 07; 22(15-16):2006-12. PubMed ID: 15121313
    [Abstract] [Full Text] [Related]

  • 25. [The prognostic markers of survival and progression in HIV-1 infection. A study of CD4+ lymphocytes, antigen p24 and viral load during 3 years in a cohort of 251 patients].
    Rubio Caballero M, Nogués Biau A, Falguera Sacrest M, Puig Ganau T, Lecha N, Rubio Rivas C.
    An Med Interna; 2000 Oct 07; 17(10):533-7. PubMed ID: 11109648
    [Abstract] [Full Text] [Related]

  • 26. Immunologic response to antiretroviral therapy in hepatitis C virus-coinfected adults in a population-based HIV/AIDS treatment program.
    Braitstein P, Zala C, Yip B, Brinkhof MW, Moore D, Hogg RS, Montaner JS.
    J Infect Dis; 2006 Jan 15; 193(2):259-68. PubMed ID: 16362890
    [Abstract] [Full Text] [Related]

  • 27. Association between tuberculosis and HIV disease progression in a high tuberculosis prevalence area.
    Badri M, Ehrlich R, Wood R, Pulerwitz T, Maartens G.
    Int J Tuberc Lung Dis; 2001 Mar 15; 5(3):225-32. PubMed ID: 11326821
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. The effects on survival of early treatment of human immunodeficiency virus infection.
    Graham NM, Zeger SL, Park LP, Vermund SH, Detels R, Rinaldo CR, Phair JP.
    N Engl J Med; 1992 Apr 16; 326(16):1037-42. PubMed ID: 1347907
    [Abstract] [Full Text] [Related]

  • 32. Stable partnership and progression to AIDS or death in HIV infected patients receiving highly active antiretroviral therapy: Swiss HIV cohort study.
    Young J, De Geest S, Spirig R, Flepp M, Rickenbach M, Furrer H, Bernasconi E, Hirschel B, Telenti A, Vernazza P, Battegay M, Bucher HC, Swiss HIV Cohort Study Group.
    BMJ; 2004 Jan 03; 328(7430):15. PubMed ID: 14703538
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.